Citations

Clear

170 citation(s) found for "Limper, Andrew".

Adoption of the Antifibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary Fibrosis
Dempsey, Timothy , Payne, Stephanie , Sangaralingham, Lindsey R. , Shah, Nilay D. , Dempsey, Timothy M , Yao, Xiaoxi , Limper, Andrew H.

Mayo Clinic

Annals of the American Thoracic Society | January 19, 2021 | Volume: 18 | Issue: 7 | Pages: 1121-1128

10.1513/annalsats.202007-901oc | PMID 33465323 Get It

Abstract Rationale In October 2014, the antifibrotic medications pirfenidone and nintedanib became the first medications approved by the U.S. Food and Drug Administration for use in patients with idiopathic pulmonary fibrosis (IPF). Since approval, there has been no nonregistry analysis of the real-world adoption of these medications in everyday clinical practice. Objectives To evaluate the adoption, persistence, and out-of-pocket (OOP) costs of pirfenidone and nintedanib since their approval in the United States in 2014. Methods A retrospective cohort analysis was performed by identifying privately insured and Medicare Advantage beneficiaries with IPF. We then split the patients into three cohorts: those who were untreated and those who filled a prescription for either pirfenidone or nintedanib between October 1, 2014, and July 31, 2019. The primary outcome was adoption of the medications. Secondary outcomes included medication persistence and prescription drug costs. Results A total of 10,996 patients with IPF were identified in the data set. A minority of patients (26.4%) with IPF identified in the cohort had started either medication since approval in 2014, with the adoption of both medications being comparable at around 13.2%. Those receiving the medications were younger (72 vs. 73.9 yr; P < 0.0001) and healthier (3.9 vs. 4.9 comorbidities; P < 0.0001) than those not receiving treatment. Men were significantly more likely to receive treatment than woman (30.0% vs. 21.9%; P < 0.0001). Among treated patients, 42.8% discontinued the medications during the study period. Patients’ OOP expenses per month were high for both drugs (mean, $397.51 for nintedanib; mean, $394.49 for pirfenidone). Conclusions The adoption of both the antifibrotic medications in the United States in everyday practice has been low since approval and may be associated with the high OOP cost.
Tissue-resident CD8 + T cells drive age-associated chronic lung sequelae after viral pneumonia
Goplen, Nick P., Wu, Yue , Son, Young Min , Li, Chaofan , Wang, Zheng , Cheon, In Su , Jiang, Li , Chini, Eduardo N. , Johnson, Aaron J. , Vassallo, Robert , Goplen, Nicholas P , Ayasoufi, Katayoun , Johnson, Aaron J. , Vassallo, Robert , Zhang, Nu , Sun, Jie , Li, Chaofan , Zhu, Bibo , Limper, Andrew H. , Sun, Jie

Mayo Clinic

Science Immunology | November 6, 2020 | Volume: 5 | Issue: 53 | Pages: No page available

10.1126/sciimmunol.abc4557 | PMID 33158975 Get It

Age-associated T RM cell malfunction supports chronic lung inflammation and tissue fibrosis after respiratory viral infection.
Grading Bleomycin‐Induced Pulmonary Fibrosis in ex vivo Mouse Lungs Using Ultrasound Image Analysis
Zhou, Boran , Shao, Juntao , Schaefbauer, Kyle, Egan, Ashley M. , Carmona, Eva M. , Zhang, Xiaoming , Schaefbauer, Kyle J., Zhang, Xiaoming , Carmona, Eva M , Limper, Andrew H.

Mayo Clinic

Journal of Ultrasound in Medicine | August 31, 2020 | Volume: 40 | Issue: 4 | Pages: 763-770

10.1002/jum.15448 | PMID 32865263 Get It

ObjectivesThe aim of this study was to assess bleomycin‐induced pulmonary fibrosis on ex vivo mouse lungs using ultrasound image grading and texture analysis.MethodsExcised mouse lungs were divided into 3 groups: control, mild fibrosis, and severe fibrosis based on the monitored indicators of health. B‐mode ultrasound images were obtained via scanning the mouse lungs ex vivo. The surface smoothness, echo density, and angle of lesions or the lung margin were graded, and the imaging contrast, correlation, homogeneity, and entropy were assessed via texture analysis.ResultsThe grades of surface smoothness, echo density, and angle were statistically higher for the severe fibrosis group compared with those of the control and mild fibrosis groups (P < .05). In addition, statistically significant differences in the contrast, correlation, and homogeneity between mild and severe fibrosis groups were observed (P < .05).ConclusionsThe results obtained in this study suggest that ultrasound image grading and texture analysis are valuable and meaningful methods for assessing pulmonary fibrosis in a bleomycin mouse model.
Targeting CARD9 with Small-Molecule Therapeutics Inhibits Innate Immune Signaling and Inflammatory Response to Pneumocystis carinii β-Glucans
Carmona, Eva M. , Limper, Andrew H. , Kottom, Theodore J. , Limper, Andrew H , Carmona, Eva M

Mayo Clinic

Antimicrobial Agents and Chemotherapy | August 20, 2020 | Volume: 64 | Issue: 11 | Pages: No page available

10.1128/aac.01210-20 | PMID 32839216 Get It

Pneumocystis jirovecii , the opportunistic fungus that causes Pneumocystis pneumonia (PCP) in humans, is a significant contributor to morbidity and mortality in immunocompromised patients. Given the profound deleterious inflammatory effects of the major β-glucan cell wall carbohydrate constituents of Pneumocystis through Dectin-1 engagement and downstream caspase recruitment domain-containing protein 9 (CARD9) immune activation, we sought to determine whether the pharmacodynamic activity of the known CARD9 inhibitor BRD5529 might have a therapeutic effect on macrophage innate immune signaling and subsequent downstream anti-inflammatory activity.
SIRT7‐mediated modulation of glutaminase 1 regulates TGF‐β‐induced pulmonary fibrosis
Choudhury, Malay , Yin, Xueqian , Schaefbauer, Kyle, Kang, Jeong Han , Leof, Edward B. , Schaefbauer, Kyle J., Kottom, Theodore J. , Roy, Bhaskar, Limper, Andrew H.

Mayo Clinic

The FASEB Journal | July 27, 2020 | Volume: 34 | Issue: 7 | Pages: 8920-8940

10.1096/fj.202000564r | PMID 32519817 Get It

Abstract In the current work we show that the profibrotic actions of TGF‐β are mediated, at least in part, through a metabolic maladaptation in glutamine metabolism and how the inhibition of glutaminase 1 (GLS1) reverses pulmonary fibrosis. GLS1 was found to be highly expressed in fibrotic vs normal lung fibroblasts and the expression of profibrotic targets, cell migration, and soft agar colony formation stimulated by TGF‐β required GLS1 activity. Moreover, knockdown of SMAD2 or SMAD3 as well as inhibition of PI3K, mTORC2, and PDGFR abrogated the induction of GLS1 by TGF‐β. We further demonstrated that the NAD‐dependent protein deacetylase, SIRT7, and the FOXO4 transcription factor acted as endogenous brakes for GLS1 expression, which are inhibited by TGF‐β. Lastly, administration of the GLS1 inhibitor CB‐839 attenuated bleomycin‐induced pulmonary fibrosis. Our study points to an exciting and unexplored connection between epigenetic and transcriptional processes that regulate glutamine metabolism and fibrotic development in a TGF‐β‐dependent manner.
Anti-Fibrotic Therapy for Idiopathic Pulmonary Fibrosis Is Associated with Decreased Mortality Among Hospitalized Patients
Kelly, B., Thao, Viengneesee , Sangaralingham, Lindsey R. , Dempsey, Timothy , Payne, S., Limper, Andrew H.

Mayo Clinic

D105. ILD EPIDEMIOLOGY II | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A7798-A7798

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7798 Get It

Respiratory Characteristics of Pulmonary Toxicity and Pneumocystis Pneumonia Associated with Bleomycin Use for Hodgkin Lymphoma
Barreto, J.N., Thompson, Carrie A. , Pawlenty, Amanda G. , Potter, Ashley , Tosh, Pritish K. , Wieruszewski, Patrick M. , Mara, Kristin C. , Limper, Andrew H.

Mayo Clinic

D44. AUTOIMMUNE AND DRUG INDUCED LUNG DISEASE | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A6846-A6846

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6846 Get It

Incidence, clinical presentation, and outcomes of Pneumocystis pneumonia when utilizing Polymerase Chain Reaction-based diagnosis in patients with Hodgkin lymphoma
Barreto, Jason N. , Thompson, Carrie A. , Wieruszewski, Patrick M. , Pawlenty, Amanda G. , Mara, Kristin C. , Potter, Ashley , Tosh, Pritish K. , Limper, Andrew H. , Potter, Ashley L , Sierzchulski, Amanda G. , Tosh, Pritish , Limper, Andrew H , Mara, Kristin C , Wieruszewski, Patrick M

Mayo Clinic

Leukemia & Lymphoma | July 5, 2020 | Volume: 61 | Issue: 11 | Pages: 2622-2629

10.1080/10428194.2020.1786561 | PMID 32623928 Get It

A critical role for CARD9 in pneumocystis pneumonia host defence
Nandakumar, Vijayalakshmi, Hebrink, Deanne, Carmona, Eva M. , Limper, Andrew H. , Kottom, Theodore J. , Hebrink, Deanne M, Limper, Andrew H , Carmona, Eva M

Mayo Clinic

Cellular Microbiology | June 17, 2020 | Volume: 22 | Issue: 10 | Pages: No page available

10.1111/cmi.13235 | PMID 32548948 Get It

Pneumocystis carinii Major Surface Glycoprotein Dampens Macrophage Inflammatory Responses to Fungal β-Glucan
Hebrink, Deanne, Carmona, Eva M. , Kottom, Theodore J. , Hebrink, Deanne M, Carmona, Eva M , Limper, Andrew H.

Mayo Clinic

The Journal of Infectious Diseases | April 24, 2020 | Volume: 222 | Issue: 7 | Pages: 1213-1221

10.1093/infdis/jiaa218 | PMID 32363390 Get It

AbstractBackgroundPneumocystis major surface glycoprotein (Msg) is a 120-kD surface protein complex on the organism with importance in adhesion and immune recognition. In this study, we show that Msg significantly impairs tumor necrosis factor (TNF)-α secretion by macrophages induced by Saccharomyces cerevisiae and Pneumocystis carinii (Pc) β-glucans.MethodsMajor surface glycoprotein was shown to greatly reduce β-glucan-induced Dectin-1 immunoreceptor tyrosine-based activating motif (ITAM) phosphorylation. Major surface glycoprotein also down regulated Dectin-1 receptor messenger ribonucleic acid (mRNA) expression in the macrophages. It is interesting that Msg incubation with macrophages resulted in significant mRNA upregulation of both C-type lectin receptors (CLR) Mincle and MCL in Msg protein presence alone but to even greater amounts in the presence of Pc β-glucan.ResultsThe silencing of MCL and Mincle resulted in TNF-α secretions similar to that of macrophages treated with Pneumocystis β-glucan alone, which is suggestive of an inhibitory role for these 2 CLRs in Msg-suppressive effects on host cell immune response.ConclusionsTaken together, these data indicate that the Pneumocystis Msg surface protein complex can act to suppress host macrophage inflammatory responses to the proinflammatory β -glucan components of the organisms.